Dova Pharmaceuticals Inc. (DOVA) Stock Overview
USA - NASDAQ:DOVA -
DOVA Key Statistics, Chart & Performance
The current stock price of DOVA is 28.04 null. In the past month the price decreased by -0.25%. In the past year, price increased by 80.9%.
DOVA Latest News, Press Relases and Analysis
About DOVA
Company Profile
Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.
Company Info
Dova Pharmaceuticals Inc.
240 Leigh Farm Road Suite 245
Durham NC 27707
CEO: David Zaccardelli
Phone: 919-748-5975
Dova Pharmaceuticals Inc. / DOVA FAQ
What does Dova Pharmaceuticals Inc. do?
Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.
What is the current price of DOVA stock?
The current stock price of DOVA is 28.04 null. The price increased by 0.14% in the last trading session.
What is the dividend status of Dova Pharmaceuticals Inc.?
DOVA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DOVA stock?
DOVA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in Dova Pharmaceuticals Inc. be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DOVA.
What is Dova Pharmaceuticals Inc. worth?
Dova Pharmaceuticals Inc. (DOVA) has a market capitalization of 807.61M null. This makes DOVA a Small Cap stock.
DOVA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to DOVA. When comparing the yearly performance of all stocks, DOVA is one of the better performing stocks in the market, outperforming 98.83% of all stocks.
DOVA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DOVA. While DOVA seems to be doing ok healthwise, there are quite some concerns on its profitability.
DOVA Financial Highlights
Over the last trailing twelve months DOVA reported a non-GAAP Earnings per Share(EPS) of -2.5599999999999996. The EPS decreased by -30.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -539.32% | ||
| ROA | -93.81% | ||
| ROE | N/A | ||
| Debt/Equity | 0.9 |